Filter Results:
(225)
Show Results For
- All HBS Web
(225)
- News (71)
- Research (135)
- Events (1)
- Multimedia (3)
- Faculty Publications (94)
Show Results For
- All HBS Web
(225)
- News (71)
- Research (135)
- Events (1)
- Multimedia (3)
- Faculty Publications (94)
- 20 Aug 2014
- News
With No Time to Lose
developed a way to measure electrical impulses in muscle tissue, and therefore measure changes in those impulses as the disease progresses. This one achievement can effectively reduce some costs associated with clinical View Details
Keywords: Margie Kelley
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
information and updates through early 2016. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/717504-PDF-ENG Harvard Business School Case 618-025 Adaptive Platform Trials: The Clinical Trial of... View Details
Keywords: Sean Silverthorne
- 01 Dec 2013
- News
Innovation as Antidote
inspiration typically comes from a very human place. DART Therapeutics CEO Gene Williams (MBA 1987) ("Your Own Medicine"), for instance, told us about a revelation he had during a 2002 trip to Rotterdam to observe clinical View Details
Keywords: Health, Social Assistance
- 01 Dec 2005
- News
Pedal Mettle
player who was diagnosed with Hodgkin’s disease in 1995, Berté saw the cancer return six months after she completed her initial treatment. She then enrolled in a clinical trial including chemotherapy,... View Details
- 19 Jun 2019
- News
Connecting Patients and Providers
traveled around the world for 20-minute appointments, but they had received vital advice from specialists in Turin, Helsinki, and Tokyo, where an applicable clinical trial was underway, via the internet.... View Details
Keywords: April White
- 01 Dec 2013
- News
Your Own Medicine
genome. Diagnosed with ALS (Lou Gehrig's disease) while at HBS, Avi Kremer (MBA 2007) and several of his classmates established Prize4Life, which offers awards to incentivize ALS research. Last year, the nonprofit also unveiled a revolutionary open-source ALS View Details
- 25 Apr 2014
- News
Bringing a new funding model to the life sciences industry
health care. "It's essentially a form of equity crowdfunding," Farquharson explains. "Since our focus is on breakthroughs in health care, success translates to dramatic improvements in clinical outcomes." Among those companies benefitting... View Details
- 01 Jun 2000
- News
The Business of Biotech
currently has drugs in clinical trials for mela-noma and breast cancer, hopes to have its first products on the market as early as 2004. "I think we're going to see more people in the next decade who are... View Details
Keywords: Julia Hanna
- 10 Oct 2000
- Research & Ideas
Cross-Sector Collaboration: Lessons from the International Trachoma Initiative
same time internally, our marketing and clinical trials folks had been working with Joe and they came to us and said, 'We've got a great opportunity here, but we do the commercial side of things and we need... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
the anatomical—basis of the disease." Genzyme, which currently has drugs in clinical trials for melanoma and breast cancer, hopes to have its first products on the market as early as 2004. "I think... View Details
- 08 Jun 2021
- News
New Funding for Female Founders
Boost VC, SV Angel, Village Global, and Threshold Ventures, according to the Wall Street Journal. Coravos is co-founder and CEO of the startup, formerly known as Elektra Labs, which helps hospitals and pharmaceutical companies employ sensor technologies to move medical... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
early detection of gynecological diseases. The Oakland-based company completed its second clinical trial and is now raising Series A funding. Its initial indications focus on identifying conditions that... View Details
Keywords: Jen McFarland Flint
- 09 Jul 2019
- Blog Post
Solving the Complexities of the Biotechnology Industry
cure its diseases, understand cancer, design clinical trials and discover molecules that can cure to the best of our abilities. Exactly for this reason, there is a vast amount of interest and capital in the... View Details
- Web
Engineering Meets Advocacy: Driving Innovation in Women’s Health - Blog: Health Supplement
Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS... View Details
- 09 Feb 2010
- First Look
First Look: Feb. 9
human patients. Doyle believes NovoCure has the potential to become an important company with a major new cancer therapy platform but must complete pivotal (Phase III) clinical trials and receive FDA... View Details
Keywords: Martha Lagace
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
ask their scientists about therapeutics they are developing as their companies grapple with both clinical trial successes and failures. Classes also will focus on the most promising advances, including... View Details
Keywords: Jennifer Gillespie
- 05 Nov 2009
- Research & Ideas
A Market for Human Cadavers in All but Name?
Cooper, Thomas A. LaVeist, and Neil R. Powe. 2004. "Whole Body Donation for Medical Science: A Population-Based Study." Clinical Anatomy 17:570-577. Clay, Megan, and Walter Block. 2002. "A Free Market for Human... View Details
- 21 Mar 2022
- Blog Post
The Impact of Career Coaching | When Mission Meets Passion
evaluating hearing healthcare investments. For example, I recently advised a company developing gene therapies for hearing loss. For the engagement, we delivered strategic recommendations for clinical trial... View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the market. This involved expanding the firm's facilities... View Details
Keywords: Martha Lagace